Cobimetinib plus vemurafenib for advanced BRAF-mutated melanoma

Initial nivolumab-based treatment halts melanoma progression

Phase III study finds initial nivolumab-based treatment halts melanoma progression

Extensive lymph node surgery may not be necessary for some patients with melanoma

Extensive lymph node surgery may not be necessary for some patients with melanoma

Comment: Research developments stir hopes for melanoma

Phase III trial shows pembrolizumab preferable to ipilimumab in advanced melanoma

Phase II trial of ipilimumab-nivolumab combo shows promise in advanced melanoma

New immunotherapy yields long-lasting responses in some patients with advanced melanoma

Investigational immunotherapy drug combo safe with early signs of effectiveness in advanced melanoma

Chk1 inhibition combined with standard dose gemcitabine may be safe and effective

Phase II trial of ipilimumab-nivolumab combo shows promise in advanced melanoma